Avadel Pharmaceuticals (AVDL)
NASDAQ: AVDL
· Real-Time Price · USD
13.69
0.19 (1.41%)
At close: Aug 15, 2025, 3:59 PM
13.64
-0.33%
After-hours: Aug 15, 2025, 07:44 PM EDT
Avadel Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 56.37M | 51.37M | 28.58M | 28.85M | 35.79M | 31.17M | 51.81M | 49.98M | 83.39M | 73.98M | 60.72M | 54.13M | 60.87M | 50.71M | 58.17M | 67.14M | 59.17M |
Short-Term Investments | 10.11M | 22.41M | 37.23M | 42.53M | 52.99M | 73.94M | 101.37M | 110.53M | 17.53M | 22.52M | 45.76M | 49.99M | 62.61M | 106.51M | 122.92M | 135.7M | 145.8M |
Long-Term Investments | n/a | n/a | n/a | 252K | 360K | 332K | 409K | 420K | 1.25M | 1.23M | n/a | n/a | n/a | 106.51M | 122.92M | 983K | 3.3M |
Other Long-Term Assets | 190K | 11.04M | 11.76M | 12.02M | 11.77M | 10.15M | 10.56M | 10.96M | 12.18M | -60.02M | 1.88M | 2.36M | 2.21M | -95.64M | -120.73M | 1.27M | 1.38M |
Receivables | 41.58M | 34.1M | 37.1M | 34.3M | 23.98M | 13.43M | 6.24M | 1.77M | n/a | n/a | 2.16M | 17.23M | 31.51M | n/a | 21.28M | 21.69M | 30.45M |
Inventory | 20.41M | 20.3M | 16.1M | 13.31M | 11.93M | 10.38M | 5.29M | 1.44M | n/a | n/a | 3.75M | 3.88M | 5.32M | n/a | 2.79M | 5.4M | 6.47M |
Other Current Assets | 825K | 882K | 8.25M | 672K | 3.32M | 913K | 2.05M | 1.79M | 3.16M | 2.82M | 844K | 480K | 434K | 32.09M | 658K | 2.18M | 1.9M |
Total Current Assets | 139.26M | 134.21M | 127.26M | 125.78M | 136.03M | 134.2M | 172.25M | 171.23M | 109.47M | 100.84M | 113.22M | 125.71M | 160.74M | 192.49M | 205.82M | 230.7M | 242.31M |
Property-Plant & Equipment | 11.66M | 2.15M | 2.4M | 2.64M | 2.9M | 3.18M | 3.45M | 1.95M | 2.26M | 2.55M | 13.82M | 13.03M | 12.76M | 2.94M | 9.45M | 8.32M | 8.32M |
Goodwill & Intangibles | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M |
Total Long-Term Assets | 28.69M | 30.03M | 31M | 31.74M | 31.86M | 126.92M | 30.84M | 29.75M | 31.27M | 31.94M | 32.54M | 32.23M | 60.39M | 54.77M | 58.27M | 51.89M | 50.63M |
Total Assets | 167.95M | 164.24M | 158.25M | 157.52M | 167.9M | 261.13M | 203.1M | 200.98M | 140.74M | 132.78M | 145.76M | 157.94M | 221.13M | 247.26M | 264.09M | 282.59M | 292.94M |
Account Payables | 9.12M | 7.33M | 7.92M | 9.79M | 18.96M | 11.43M | 13.26M | 11.79M | 10.02M | 7.89M | 2.48M | 7.32M | 6.05M | 7.68M | 6.87M | 5.12M | 2.82M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 17.96M | 17.58M | 40M | n/a | n/a | 11.43M | n/a | 7.15M | 9.82M | 10.22M | 5.38M |
Short-Term Debt | n/a | 582K | n/a | n/a | 953K | 934K | 22.1M | 21.63M | 20.52M | 38.63M | 27.31M | 27.17M | 27.1M | 900K | 504K | 494K | 484K |
Other Current Liabilities | 20.3M | 32.52M | 34.14M | 11.39M | 21.62M | 16.06M | 5.42M | 3.9M | 46.37M | 6.7M | 9.42M | 2.99M | 8.2M | 2.62M | 2.29M | 1.46M | 691K |
Total Current Liabilities | 50.93M | 48.83M | 42.78M | 44.61M | 47.81M | 36.85M | 54.05M | 51.5M | 79.36M | 55.79M | 41.51M | 46.22M | 44.02M | 21M | 17.59M | 16.28M | 9.12M |
Long-Term Debt | n/a | n/a | n/a | 35.49M | 34.33M | 32.76M | n/a | n/a | 93.14M | 91.61M | 109.93M | 108.07M | 116.53M | 142.4M | 142.09M | 141.77M | 141.46M |
Other Long-Term Liabilities | 40.76M | 40.43M | 39.59M | 5.82M | 5.92M | 5.65M | 36.97M | 5.79M | 5.77M | 5.74M | 5.73M | 5.72M | 3.85M | 3.92M | 4M | 4.07M | 4.14M |
Total Long-Term Liabilities | 42.95M | 41.55M | 40.81M | 42.62M | 41.71M | 136.53M | 38.9M | 6.28M | 99.54M | 98.14M | 116.69M | 115.05M | 121.87M | 148.02M | 147.54M | 147.43M | 147.32M |
Total Liabilities | 93.88M | 90.39M | 83.59M | 87.23M | 89.52M | 173.39M | 92.95M | 57.78M | 178.91M | 153.93M | 158.2M | 161.27M | 165.9M | 169.02M | 165.13M | 163.71M | 156.44M |
Total Debt | 2.9M | 1.7M | 1.94M | 37.67M | 36.73M | 35.38M | 24.03M | 22.12M | 115.16M | 131.02M | 138.27M | 136.51M | 145.13M | 145M | 144.05M | 143.86M | 143.66M |
Common Stock | 966K | 965K | 963K | 961K | 960K | 898K | 893K | 893K | 644K | 628K | 608K | 590K | 590K | 586K | 586K | 584K | 584K |
Retained Earnings | -799.25M | -794.33M | -789.28M | -786.66M | -772.84M | -745.5M | -716.71M | -680.44M | -616M | -585.22M | -557.77M | -537.62M | -474.18M | -447.76M | -425.45M | -403.45M | -383.87M |
Comprehensive Income | -24.31M | -24.58M | -23.8M | -24.21M | -23.76M | -23.17M | -25.95M | -25.94M | -26.03M | -26.34M | -27.91M | -26.33M | -25.04M | -23.94M | -22.74M | -22.35M | -22.31M |
Shareholders Equity | 74.07M | 73.85M | 74.66M | 70.29M | 78.38M | 87.74M | 110.15M | 143.19M | -38.17M | -21.14M | -12.44M | -3.33M | 55.23M | 78.24M | 98.96M | 118.88M | 136.5M |
Total Investments | 10.11M | 22.41M | 37.23M | 42.79M | 53.35M | 74.28M | 101.37M | 110.53M | 17.53M | 22.52M | 45.76M | 49.99M | 62.61M | 213.03M | 245.85M | 135.7M | 145.8M |